and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against the new variant which 1st emerged there. to end up with a situation that in a certain 1000000 people or 2000000 people that seem to me not be effective in preventing hospitalization and severe disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses are being bought by turkey alone. and moscow to profess to do its own deals. iran just the latest to get russia's sputnik the vaccine. the kovacs program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one world protecting. extreme freezing wea

richer nations are accused of using it as an added extra and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against the new variant which 1st emerged there. the situation is actually newton 1000000 people or 2000000 people seeing that may not be effective in preventing hospitalization and so the disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses of being bought by turkey alone. and moscow to prefers to do its own deals. iran just the latest to get russia's sputnik v vaccine. fax program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one. protected. joinin

decade of action and that in i think the feeling of the jobs come from 2 sources the oxford university astra zeneca cova shield vaccine and kovacs it which is developed by the indian pharmaceutical company bharat biotech now pennsylvania based oxygen inc wants to bring kovacs into the states the biopharmaceutical company which traditionally deals with fighting blindness has entered an agreement with india's bharat biotech oxygen tweeted we are excited to announce the definitive agreement for the commercialization of kovacs in the us with bharat biotech and share in the us commercialization profits kovacs and received emergency use authorization approval in india in january according to a press release from oxygen the company plans to receive an initial supply of kovacs and doses from bharat biotech once the vaccine is approved by u.s. regulatory authorities in the meantime it will ramp up its own manufacturing process of the vaccine in the us while the vaccine is already being used in india due to the emergency use authorization it is simultaneously in its phase 3 of clinical trials involving 25800

and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against a new variant which 1st emerged there. could a situation that's an asian 1000000 people or 2000000 people that seem to me not the effective in preventing hospitalization and severe disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses of being bought by turkey alone. and moscow to prefers to do its own deals iran just the latest to get russia's sputnik v vaccine. the kovacs program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one world protected. leaders of germany and france will di

the age of 50 and test the effectiveness of 4 combinations of 1st and 2nd shots of the astra zeneca oxford university vaccine and the fires are biotech vaccine results of the trials are not actually expected into.

and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against the new variant which 1st emerged there. to end up with the situation vaccination 1000000 people or 2000000 people that's in that may not be effective in preventing hospitalization and severe disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses of being bought by turkey alone. and moscow 2 prefers to do its own deals. iran just the latest to get russia's sputnik v. vaccine. and the kovacs program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one world protected. the leaders of german

the age of 50 and test the effectiveness of 4 combinations of 1st and 2nd shots of the astra zeneca oxford university vaccine and the pfizer biotech vaccine results of the trials are not actually expected until june or july on thursday u.k. minister for coping 19 vaccine deployment that he was how we promised this would not affect the current vaccine rollout and spoke about the work done to make sure vaccines would protect against the roughly $4000.00 variants of the virus all managed matches by an attacker but done a cool spot should cost money and dollars are looking at how we can improve them actually to make sure that we are ready for any veteran ramos out of batteries round are well over now and with tb and library of all the very ones we're ready to be able to respond more than the will to all be on any kind of bothers me present and produce next baxley. so with this in mind let's take a look at the state of the vaccine rollout as well as the trends and spread of the virus with r.t. correspondent science having her silent where are we thursday sybren here in the us as since the accident should

above the age of 50 and test effectiveness of 4 combinations of 1st and 2nd shots of the astra zeneca oxford university vaccine and the fires are biotech vaccine results of the trials are not actually expected until june or july on thursday u.k. minister for coping 1000 vaccine deployment that. the how we promised this would not affect the current vaccine rollout and spoke about the work done to make sure vaccines would protect against the roughly $4000.00 variants of the virus all monies that she has a biotech. and dollars are looking at how the. vaccine to make sure that we are ready and a very robust force 1000 barriers around well. now and will keep me alive all the bearings we're ready to be able to. all be on. charlie bars me and. so with this in mind let's take a look at the state of the vaccine rollout as well as the trends and spread of the virus with r.t. correspondent saya tavenner so where are we thursday so brand here in the u.s. since vaccination have started which obviously hasn't been long about $27000000.00 people have received at least one dose of the coven $1000.00 vaccine including

over to europe where we start in london the footsie is also despite concerns over the astra zeneca oxford university kovan $1000.00 vaccine the company reported a 10 per cent rise in profit year over year but shares just edged a little bit lower official data released on friday showed the country's economy contracted by 9.9 percent in 2020 the french cac and german docks they're both down both in the red german 2nd largest wonder commerzbank shares plunged 6 per cent over a weaker than expected outlook for the year 2021 in france l'oreal saw gains of 1.5 percent after a better than expected earnings let's head over to brazil where the evil best buy is in the red the rails slid earlier in the week inflation in the country so to an annual $4.00 per 56 percent rate that's above central bank school of 3.75 percent a friday report also showed economic activity in the nation fell just over 4 percent just last year and mexico the b.m.v. is just barely down the mexican central bank cut key interest rates for the 1st time that since september by 25 basis points to 4 percent now the move shows some concern ov

richer nations are accused of using it as an added extra and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against a new variant which 1st emerged there. and up to the situation vaccinated 1000000 people or 2000000 people that seem to me not being effective in preventing hospitalization and severe disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses are being bought by turkey alone. and moscow to prefers to do its own deals. iran just the latest to get russia's sputnik v. vaccine. the kovacs program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one. prote

and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against the new variant which 1st emerged there we don't want to end up with a situation where we vaccinate a 1000000 people or 2000000 people vaccine that may not be effective in preventing hospitalization and severe disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold or donated large quantities of its 3 vaccines to countries around the world. 50000000 doses it being bought by turkey alone. and moscow to profess to do its own deals. iran just the latest to get russia's sputnik v vaccine. the kovacs program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one world protected. now to s

at the same time a new study shows the shot developed by the drug from astra zeneca and oxford university remains highly effective for 3 months after a single dose. i'm captain so tell me more the 100 year old veteran who raised millions of pounds for british health workers during knock down has died your chief aim of to setting himself a target to walk laps of his garden ended up with a total of $43000000.00 so tom was taken to hospital with pneumonia and had tested positive for corona virus britain's prime minister has described him as a hero in the truest sense of the word. there's a top stories do stay with us out as their world continues next idea. for. the sultanate of our mind has a rich history and was once the dominant power in the whole gulf region it had a powerful navy and colonized large areas of east africa in the 17th and 18th centuries. the alba sided dynasty came to power in 749 and the same family still rules online today in 1806 sorry had been sold on a booze idea took power. but by the early 18 hundreds other tribes like the on the northern coast had their own separati

at the same time a new study shows the shot developed by the drug for astra zeneca and oxford university remains highly effective for 3 months after a single dose. and captain so told more the 100 year old veteran who raised millions of pounds for british health workers during lockdowns has died here chief a martyr setting yourself a target to walk laps of his garden he ended up with a total of $43000000.00 tom was taken to hospital with pneumonia and had tested positive for corona virus was the top stories do stay with us the fans who make football is up next more news after that of the 1st and if you don't i will. tell you when you. 'd get. to what you. can you do enough. to learn on your behalf you. can even. through it. was. that. there are that. i. the magaluf are a stay at home to slay man for all i. hear on these terraces a revolution is happening it's impacting not only football but also indonesian society. we're seeing the rise of a pioneering group of female ultra fans and they're taking age by storm i. internees this country has the largest muslim population in the world. yogy

latin america and just 57 percent among volunteers in south africa meanwhile data from astra zeneca and oxford university vaccine. the drug to be 90 percent effective when given a half dose followed by a full dose at least one month apart however the data also shows 62 percent of african c. when given into full doses over that same time period combined analysis by astra zeneca shows an average of 70 percent efficacy across both doses there are currently concerns in europe over the safety of the back seat for the elderly popular population with all of this in mind let's go ahead and take a look at the global vaccine rollout with our 2 correspondents cited chapter sarwari sober and 1st i want to continue something about the russians wouldn't agree that you were just talking about that you know all along they were saying that this would not be at a very high efficiency against coburn 1000 but if you recall russia also faced a lot of international criticism after the vaccine was 1st approved before they actually released their data from clinical trials now they have since released their data which was publis

possibility just struck me when you said mentioned that i have one last question correa astra zeneca at oxford university they're running a trial for their vaccine in children ages 6 to 17 years old while pfizer and modernity haven't ruled children ages 12 and older for trials of their vaccine hoping to have results by the summer one of the safety concerns for testing a vaccine in children and what additional safeguards need to be put in place at this point. well those trials will tell the story what's the best toast and are children going to have similar side effects that we do we need to know that very clearly adolescents young children and even down to infants we're going to do that in a very sober graduated way to make sure that when we start thanks navy children be can tell parents exactly what to expect on that vaccine to be safe as well as effect dr william schaffner as i've said many times i can't tell you how much we appreciate your expertise on the program vaccine specialist at vanderbilt university thank you so much for your time today. my pleasure. and finally british luxury automaker jaguar

at the same time a new study shows the short developed by the drug for astra zeneca and oxford university for maine's highly effective for 3 months after a single dose it supports decisions made by countries including the u.k. to delay the 2nd dose needed for longer term protection there's the top stories do stay with us and i was there at the stream is up next hour more news for you dr death. our family ok welcome to the stream in a global pandemic it makes sense for every country whether there were a developing country or a developed country to have access to life saving coverage in fact seeds but this is not the case as the director general of the w.h.o. the world health organization dr to cross explained recently. i do is to reach under these are only no adverse events to their citizens while the world is the least of all of the countries wards and would this is not all this is not only leaves the ones most vulnerable people are the risks it's also short sighted and self defeating the us emotionalism will only prolong the bundle that a solution is needed to contain it. yeomen learn le

astra zeneca. in london so neither house astra zeneca reacting to the south african government's decision to suspend its tanks in. well essentially the oxford university astra zeneca team are confirming what the researchers in south africa are saying according to preliminary data oxford university ses the still needs to be peer reviewed the full details to come in the coming days yes indeed the oxford asked astra zeneca vaccine is minimally effective against people with mild forms of the virus what oxford have confirmed is though that the research did not assess people with serious infection serious strains of the 19 south african strain but the hope is given that the research carried out in south africa suggests that they could still be an impact on reducing the number of people needing serious treatment or ending up in hospital it still has a degree of effectiveness and still should be administered there is a right of light here in the message from the oxford team is that the existing vaccines could indeed be tweaked and very quickly without the need for a large clinical trial afterwards it appears and we've known this for some time that they take o

and critically and also reducing the death toll as well saying that though astra zeneca and scientists from oxford union university have been forced to concede that the vaccine hasn't behaved as they wanted to astra zeneca said that the response was indeed the limit is but there is still some light the oxford research is sort of implied that they can quite easily without having to go back to square one tweak the ostrich oxford astra zeneca vaccine so that it will be effective without having to go through the whole process over a big trial after that so the groundwork has already been laid the vaccine still has a role to play in south africa and still has a role to play as a building block for another potentially successful vaccine to deal with the south african strain. that live from london thank. dozens of people are still trapped in a tunnel a day off to part of a himalayan glassy a collapsed fell into a river causing a massive flood at least 20 bodies have been recovered 200 more people and missing is a bit further now reports from just the math in the foothills of the himalayas. the rescuers are relying on hea

astra zeneca is reaction let's speak to me barker he's joining us from london so neither have we heard from the drug maker. we have in day we've heard from astra zeneca and researchers oxford university and the both of them of course of have to concede that their vaccine isn't as effective as hoped against the south africa strain astra zeneca saying that its scope was limited oxford research is saying that its service spawns was minimal to maal to moderate infections of the south africa strain what we don't know really because no research has yet been done in full is the impact on serious infections of south africa strain but the shared opinion formed leading scientists in south africa and here in the u.k. is a hopeful one but it could indeed still prevent the worst effects of that strain preventing people from ending up in hospital and also preventing people from of course dying off this serious as well which is the message that johnson the british prime minister has been very keen to hit home i think largely over fears that this news in some way undermines britain's very very successful vaccine rollout today we know that more than 12000000 people have had at least one dose of a vac

astra zeneca vaccine instead they will vaccinate some people at some point but at the same time continue studies to understand better how to use astra zeneca. study a johannesburg's with university shows 2 doses of the oxford astra zeneca vaccine provides a minimal protection against mild to moderate infections of the south african variant the study didn't assess efficacy against severe infections but the author said the findings show efforts should shift from herd immunity to protecting people at risk of getting covert scientists to lead the development of the astra zeneca vaccine said the study confirms the virus will find ways to spread in vaccinated populations researchers noted work is underway on a 2nd generation of the vaccine that will target new mutations. dr clear cut lenses of the astra zeneca trial coordinator in south africa she says the country was depending on the astra zeneca vaccine for its immunization program it's being a disappointing state fact that we had the only vaccines that are carrying the. in country in so africa the escalating thanks even which is seen as domenici the original virus the don't send in johnson parents made an application to date people each separately who are. cr

britain is one of many countries that has bought large amounts off of r c developed by oxford university and astra zeneca. at the weekend south africa suspended plans to launch a mass vaccination program using that vaccine study showed that even though it largely prevents the illness from getting serious it offered less protection against mild to moderate illness caused by the virus variant that originated in south africa to the abuse everyone creech reports from that. it was supposed to be the turning point in south africa's fight against corporate 19 the arrival of 1000000 doses of the astra zeneca havoc seen last week presidents who run up was and the health minister came to receive it personally but the doses will remain in storage for now and you study suggests the vaccine appears to offer only minimal protection against mild and moderate disease from the new variants that was discovered in south africa the government's roll out plan is now on hold. if we want to send is a risk what do we do with a citizen you can. just dream. it is watching what. we do upward so there is no potential sense because

the virus well now a new study suggests that the oxford astra zeneca shot couldn't be prevent people from spreading 19 the research by oxford university is the 1st to show a vaccine stopping the corona virus being passed on as well as protecting against you know university says the vaccine could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated. the british health minister matt hancock had this to say about the new findings at this. report is a very good news at 8 'd backs the strategy that we've taken and shows the well the often vaccine works effectively and the really good news embedded in it is that it milt just reduces hospitalizations that we know people in this part of the trial who hospitalized. do we kind of add up to getting the job but also it reduces the number of people who have actual even a symptomatically by around 2 thirds well the technology being used in that vaccine from another vaccine for biotech pfizer and others also promises to become powerful new weapon in the fight

astra zeneca. or the study and johannesburg university shows 2 doses of the oxford astra zeneca vaccine provides many more protection against miles to moderate infections of the south african variant of cover 19 the study didn't assess advocacy against severe infections where the authors said the findings show efforts should shift from head immunity to protecting people at risk of getting covered the scientists who lead the development of the. astra zeneca vaccine says a study confirms the virus will find ways to spread in vaccinated populations researchers noted work is underway on a 2nd generation of the vaccine that will target new mutations early i spoke to dr helen reese who is a member of south africa's ministerial advisory committee for cold feet in the cold vaccine she explains how health authorities will use this study in their. so this was a very important study it was a small number of people and it was a young cohort which meant that just in terms of the natural history not many of them were anyway going to get severe disease that means the only thing that it could show was that there is

corona virus well now a new study suggests the oxford astra zeneca shot could indeed prevent people from spreading covert 19 the research by oxford university is the 1st to show a vaccine stopping the corona virus being passed on as well as protecting against the illness the university says the back seam could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated british health minister matt hancock had this to say about the new study at this. report is a very good news at 8 backs the strategy that we've taken and it shows the world that the oxford vaccine works effectively and the really good news embedded in it is that it not just reduces hospitalizations that we know people in this part of the trial who hospitalized. do with covais that after getting the ox jab but also it reduces the number of people who have actually even asymptomatic by around 2 thirds. comments from the british health minister there well earlier we spoke to paul or hunter he's a professor of medicine at the university of east an

decade of action intended and i think the feeling of all the jobs come from 2 sources the oxford university astra zeneca cobra shield vaccine and kovacs it which is developed by the indian pharmaceutical company bharat biotech now pennsylvania based oxygen inc wants to bring kovacs into the states the biopharmaceutical company which traditionally deals with fighting blindness has entered an agreement with india's bharat biotech oxygen tweeted we are excited to announce the definitive agreement for the commercialization of kovacs and in the us with bharat biotech and share in the us commercialization profits kovacs and received emergency use authorization approval in india in january according to a press release from oxygen the company plans to receive an initial supply of kovacs in doses from by.

decades of action intended and i think the feeling of all the jobs come from 2 sources the oxford university astra zeneca cobra shield vaccine and kovacs it which is developed by the indian pharmaceutical company bharat biotech.

decades of action has been made and i think the fear of the jobs come from 2 sources the oxford university astra zeneca cova shield vaccine and kovacs it which is developed by the indian pharmaceutical company bharat biotech now pennsylvania based oxygen inc wants to bring kovacs into the states the biopharmaceutical company which traditionally deals with fighting blindness has entered an agreement with india's bharat biotech tweeted we are excited to announce the definitive agreement for the commercialization of kovacs in the us with bharat biotech and share in the us commercialization profits kovacs and received emergency use authorization approval in india in january. according to a press release from oxygen the company plans to receive an initial supply of kovacs and doses from brought biotech once the vaccine is approved by u.s. regulatory authorities in the meantime it will ramp up its own manufacturing process of the vaccine in the u.s. while the vaccine is already being used in india due to the emergency use authorization it is simultaneously in its phase 3 of clinical trials involving 25800 pa

last week south africa received 1000000 astra zeneca doses and was due to sars not collations in the next few days all that study. university shows 2 doses of the oxford astra zeneca vaccine provide minimal protection against mild to moderate infections of the south african variant the study didn't assess the efficacy against severe infections but the office said the findings show efforts should shift from herd 'd immunity to protecting people at risk of getting cove it and scientists to lead the development of the astra zeneca vaccines of the study confirms the virus will find ways to spread in vaccinated populations researches noted work is underway on a 2nd generation of vaccine that will target new mutations the mother is in johannesburg and says the government had already come under criticism for its slow vaccine rollout. according to the studies that have been done and we are expecting that full study to be published sometime today 2000 participants were studied with regard to the response to astra zeneca and the government has said that it shows that there is only a 22 percent efficacies rate when trying to prevent mild or moderate covert 19 no

defeating the virus well now a new study suggests the oxford astra zeneca shot could indeed prevent people from spreading cohabit 19 research but oxford university is the 1st to show a vaccine stopping the corona virus being passed on as well as protecting against the onus the university says the vaccine could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated. british health minister met hancock had this to say about the new study. i think this. report is a very good news it's 'd backs the strategy that we've taken and it shows the world that the oxford vaccine works effectively and the really good news embedded in it is that it not just reduces hospitalizations there were no people in this part of the trial who were hospitalized. with covariate after getting off the job but also it reduces the number of people who have coverage after all even a symptomatically by around 2 thirds. well technology being used in another covert 900 bucks in co-developed tech has promised to become a powerful new weapon in

prioritize its production of the astra zeneca vaccine for the indian market and a study from the university of edinburgh us found that vaccinations from biotech sizer and oxford astra zeneca have led to a substantial reduction in hospital admissions in scotland. and now to some other headlines from around the world facebook says it will lift a ban on australian news pages in the coming days after reaching a compromise with the government over paying for media content the australian government has agreed to make changes to a law and not to penalize facebook if the company reaches some deals with local media canada's parliament has passed a non-binding motion saying that china's treatment of weaker muslims and shin jiang amounts to genocide prime minister justin trudeau in his cabinet abstained from the vote china has condemned and rejected the motion from. the leader of georgia's main opposition party has been arrested become aliased attention comes days after the prime minister resigned amid a debate over whether to take the opposition politician into custody elliott faces charges of inciting violence during protests in 2019 he dismisses the charges as politi

prioritize its production of the astra zeneca vaccine for the indian market and a study from the university of edinburgh has found that vaccinations from biotech pfizer and oxford astra zeneca have led to a substantial reduction in hospital admissions in scotland. now let's get a roundup of some other headlines at this hour canada's parliament has passed a non-binding motion saying that china's treatment of we go muslims and shin jang amounts to genocide prime minister justin trudeau at this cabinet abstained from the vote china has condemned and rejected the motion of the leader of georgia's main opposition party has been arrested nicam aliased attention comes days after the prime minister resigned amid a debate over whether to take the opposition politician into custody faces charges of inciting violence during protests in 2019 he dismisses the charges as politically motivated. and authorities in the democratic republic of congo have blamed rwandan hutu rebels for the killing of italy's ambassador he was one of 3 people killed when a convoy from the world food program came under fire the president of the d r c has called the ambush a terrorist attack. me and

new studies suggest the oxford astra zeneca shot could indeed prevent people from spreading kovac 19 the research by oxford university is the 1st to show a vaccine stopping the corona are is being passed on as well as protecting against the illness the university says the vaccine could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated the british health minister matt hancock has welcomed the studies like this. this. report is a very good news it's 'd backs the strategy that we've taken and it shows the world that the oxford vaccine works effectively and the really good news embedded in it is that it not just reduces hospitalizations there were no people in this part of the trial who were hospitalized. with covais that after getting your job but also it reduces the number of people who have actually even a symptomatically by around 2 thirds. good news indeed but will this be enough to stop community transmission of the virus earlier we spoke to paul r. hunter he's a professor

corona virus well now a new study suggests the oxford astra zeneca shot could indeed prevent people from spreading covert 19 the research by oxford university is the 1st to show a vaccine stopping the corona virus being passed on as well as protecting against the illness the universities as the vaccine could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated the british health minister met hancock has welcomed the study's findings. this oxford report is a very good news it 'd backs the strategy that we've taken and it shows the world that the oxford vaccine works effectively and the really good news embedded in it is that it not just reduces hospitalizations there were no people in this part of the trial who were hospitalized. with covariate after getting your job but also it reduces the number of people who have care of it at all even a symptomatically by around 2 thirds 10 years indeed but will this be enough to stop community transmission of the virus earlier we spoke to paul r. hunter he's a pro